Clinical Trial Update: Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Impracor (ketoprofen 10% cream) versus placebo for acute pain flares in knee osteoarthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Impracor (ketoprofen 10% cream)

Snippet

Sponsor: Imprimis Pharmaceuticals, Inc. | Conditions: Acute Pain (Flare) Associated With Osteoarthritis (OA) of the Knee | Phase 3 | Status: WITHDRAWN